Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Metabolic Syndrome X: later-stage trial registry

A small indexed set (11 trials) with no open enrollment listed right now.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · none currently recruiting · #1,577 of 28,707 conditions by registered trial count

Metabolic Syndrome X: 11 US clinical trials tracked, none currently recruiting.

Metabolic Syndrome X is the subject of 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 5 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Foundation Research, Florida, running 1 of these trials.

Enrollment posture brief

Registry condition metabolic-syndrome-x

OPEN 0 | RECR 0% | LATE 5 | EARLY 2 | RANK #1577 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%Metabolic Syndrome X (this)0%
Open-enrollment share among volume-matched conditions near Metabolic Syndrome X

Metabolic Syndrome X has no open enrollment in this registry pull (11 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Metabolic Syndrome X on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Metabolic Syndrome X is recruiting below its size-band peers.

    0 of 11 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Metabolic Syndrome X trials is spread across many organizations.

    Foundation Research, Florida accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Most Metabolic Syndrome X trials plan to enrol fewer than 100 people.

    Median target enrolment is 36 among the 11 trials that report a genuine target (sentinel values excluded). 9 of those (81.8%) plan for fewer than 100 participants.

  4. Metabolic Syndrome X research is mostly interventional.

    11 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 45

Indexed trials (enrollment closed)

11 total, page 1 of 1

COMPLETED Phase 2 261 participants

Effects of Resistance and Aerobic Exercise on Cardiovascular Health

Duke University

NCT00275145

COMPLETED NA 114 participants

Collaborative Care for Heart Failure Patients With the Metabolic Syndrome

Baylor College of Medicine

NCT00293852

COMPLETED Phase 4 77 participants

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Veterans Medical Research Foundation

NCT00338949

COMPLETED Phase 4 70 participants

Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

Florida Atlantic University

NCT00272311

COMPLETED Phase 4 46 participants

Oral Contraceptives in the Metabolic Syndrome

Virginia Commonwealth University

NCT00205504

COMPLETED Phase 2 36 participants

Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells

Emory University

NCT00166036

COMPLETED Phase 4 30 participants

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

Foundation Research, Florida

NCT00304993

COMPLETED NA 30 participants

Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers

Tufts University

NCT00175084

COMPLETED NA 26 participants

Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults

Columbia University

NCT02347007

COMPLETED Phase 4 21 participants

Diurnal Variation of Plasminogen Activator Inhibitor-1

Vanderbilt University Medical Center

NCT00515021

COMPLETED NA 16 participants

Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption

Ohio State University

NCT02918422

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 5

Named interventions

Most-linked intervention names on Metabolic Syndrome X records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ortho Tri Cyclen Drug
1 trials
Nutritional and Dietary Manipulation Other
1 trials
Outpatient clinic follow-up Procedure
1 trials
Cereal Bar Dietary supplement
1 trials
Almond Dietary supplement
1 trials
Comparison of dietary protein amino acid profile Behavioral
1 trials
Eplerenone (Night-time) Drug
1 trials
Eplerenone (Morning) Drug
1 trials

US sites by state

Facility locations filed on Metabolic Syndrome X trials. A trial with sites in several states counts in each.

Virginia 1 trials
Texas 1 trials
Tennessee 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials
Maryland 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Metabolic Syndrome X page

11 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Metabolic Syndrome X trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Foundation Research, Florida sponsors the most Metabolic Syndrome X trials on record, review their full trial history before evaluating a specific study. See Foundation Research, Florida's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metabolic Syndrome X condition card totals 11 registered trials; most-linked intervention Ortho Tri Cyclen; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.